BIOPOR Bioporto A/S

BioPorto A/S - Annual General Meeting

BioPorto A/S - Annual General Meeting

April 14, 2020

Announcement no. 9

BioPorto A/S - Annual General Meeting

Today, BioPorto A/S held its Annual General Meeting during which the report on the Company’s activities was reviewed and the 2019 Annual Report was adopted. The proposed profit/loss allocation was also adopted and discharge of liability was granted to the Board of Directors and the Executive Management. Finally, the remuneration for the Board of Directors was approved.

Thomas Magnussen, Torben A. Nielsen, Kirsten Aarup Drejer, Christopher Lindop and Michael S. Singer were re-elected as members of the Board of Directors. Immediately following the Annual General Meeting, the Board of Directors elected Thomas Magnussen as its Chairman and Torben A. Nielsen as its Vice Chairman. 

The proposals from the Board of Directors under item 6 of the agenda were all adopted, and included: a) Amending the Articles of Association regarding shareholders’ notification of attendance for a general meeting, b) Amending the standard agenda for the Annual General Meeting in Article 8 in the Articles of Association, c) Renewing the authorization to issue warrants for up to DKK 2,500,000 following decision by the Board of Directors to amend its original proposal of up to DKK 6,600,000 shares, d) Approving the Company’s revised Remuneration Policy and e) Authorization to the Chairman of the general meeting.

PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab was re-elected as the Company’s auditor.

Hellerup, April 14, 2020

BioPorto A/S

The Board of Directors

For further information, please contact:

Peter Mørch Eriksen, CEO

Ole Larsen, CFO

Telephone , e-mail:

About BioPorto

BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].

Attachment

EN
14/04/2020

Underlying

BIOPORBioporto A/S

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioporto A/S

 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Ændringer i selskabets Direktion

Ændringer i selskabets Direktion 11. december 2025 Meddelelse nr. 29 Ændringer i selskabets Direktion KØBENHAVN, DANMARK og BOSTON, MA, USA, 11. december 2025 (GLOBE NEWSWIRE) – BioPorto A/S ("BioPorto") (CPH:BIOPOR) meddelte i dag, at Niels Høy Nielsen har opsagt sin stilling som CFO for BioPorto for at tiltræde en CFO-stilling i et andet selskab. "Jeg har værdsat det tætte samarbejde med Niels i de sidste par måneder, siden jeg tiltrådte min stilling i BioPorto. Niels har ydet vigtige bidrag til virksomheden og jeg ønsker ham alt det bedste i hans fremtidige stilling," sagde Carsten B...

December 11, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Changes to the Executive Management

Changes to the Executive Management December 11, 2025 Announcement no. 29                                                                          Changes to the Executive Management COPENHAGEN, DENMARK and BOSTON, MA, USA, December 11, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto”) (CPH:BIOPOR) announced today that Niels Høy Nielsen has resigned as CFO of BioPorto to become CFO at another company. “I have valued the close collaboration with Niels during the last couple of months since I joined BioPorto. He has made important contributions across the company and wish him all the bes...

December 11, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Ledende medarbejderes transaktioner

Ledende medarbejderes transaktioner 24. november 2025Meddelelse nr. 28                                                                          Ledende medarbejderes transaktioner I forbindelse med gennemførelsen af BioPorto A/S' rettede emission, som beskrevet i selskabsmeddelelse nr. 27, har BioPorto A/S i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget indberetning af nedenstående transaktioner vedrørende aktier i BioPorto A/S foretaget af personer med ledelsesansvar i BioPorto A/S og/eller nærtstående til disse. 1 Nærmere oplysninger om personen med ledelsesansvar/pers...

November 24, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Managers’ transactions

Managers’ transactions  November 24, 2025Announcement no. 28                                                                          Managers’ transactions In connection with the completion of BioPorto A/S’ directed issue as described in company announcement no. 27, BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely associated with them. 1 Details of the person discharging managerial responsi...

November 24, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i anta...

BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i antal aktier og stemmer 24. november 2025 Meddelelse nr. 27                                                                          BioPorto A/S rejser ca. 43 mio. kr. i ny kapitalrunde - Ændring i antal aktier og stemmer Gennemførelse af kapitalforhøjelse København, Danmark, 24. november 2025, (GLOBE NEWSWIRE) - Bestyrelsen for BioPorto A/S ("BioPorto" eller "Selskabet") (CPH:BIOPOR) besluttede den 13. november 2025 at gennemføre en rettet emission af 40.438.426 nye aktier til eksisterende større aktionærer, nye instit...

November 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch